Ensysce Biosciences Announces Critical Step in Human Abuse Potential Study of PF614 With Database Lock

Company Remains on Track to Report Results the End of MarchSAN DIEGO, CA / ACCESSWIRE / February 28, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage biotech company applying transformative chemistry to …